On November 29, 2022 AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, reported that chief medical officer Robert O. Dillman, M.D., will chair and deliver the opening remarks for the Cancer Immunotherapy track at World Vaccine and Immunotherapy Congress West Coast, taking place Nov 28 – Dec 1 in San Diego, California (Press release, AIVITA Biomedical, NOV 29, 2022, View Source [SID1234624531]). Dr. Dillman will also share updates on AIVITA’s personal dendritic cell vaccine platform during a plenary presentation in the Cancer Immunotherapy track. Speaking details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!